公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study | Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii | Hepatology | | | |
2022 | Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | Lau, George; Yu, Ming-Lung; Wong, Grace; Thompson, Alexander; Ghazinian, Hasmik; Hou, Jin-Lin; Piratvisuth, Teerha; Jia, Ji-Dong; Mizokami, Masashi; Cheng, Gregory; Chen, Guo-Feng; Liu, Zhen-Wen; Baatarkhuu, Oidov; ANN-LII CHENG ; Ng, Woon Leung; Lau, Patrick; Mok, Tony; Chang, Jer-Ming; Hamid, Saeed; Dokmeci, A Kadir; Gani, Rino A; Payawal, Diana A; Chow, Pierce; Park, Joong-Won; Strasser, Simone I; Mohamed, Rosmawaiti; Win, Khin Maung; Tanwandee, Tawesak; Sarin, Shiv Kumar; Omata, Masao | Hepatology international | 0 | 0 | |
2021 | Multi-Institutional Retrospective Study of Radiotherapy for Hepatocellular Carcinoma in the Caudate Lobe | Lee, Sung Uk; Yoon, Sang Min; CHIA-HSIEN CHENG ; Kim, Tae Hyun; Kim, Bo Hyun; Park, Jin-Hong; Jung, Jinhong; CHIAO-LING TSAI ; YUN CHIANG ; Park, Joong-Won | Frontiers in oncology | 3 | 1 | |
2022 | Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial | Yau, Thomas; Park, Joong-Won; Finn, Richard S; ANN-LII CHENG ; Mathurin, Philippe; Edeline, Julien; Kudo, Masatoshi; Harding, James J; Merle, Philippe; Rosmorduc, Olivier; Wyrwicz, Lucjan; Schott, Eckart; Choo, Su Pin; Kelley, Robin Kate; Sieghart, Wolfgang; Assenat, Eric; Zaucha, Renata; Furuse, Junji; Abou-Alfa, Ghassan K; El-Khoueiry, Anthony B; Melero, Ignacio; Begic, Damir; Chen, Gong; Neely, Jaclyn; Wisniewski, Tami; Tschaika, Marina; Sangro, Bruno | The Lancet. Oncology | 444 | 433 | |
2022 | Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma | Rimassa, Lorenza; Kelley, Robin Kate; Meyer, Tim; Ryoo, Baek-Yeol; Merle, Philippe; Park, Joong-Won; Blanc, Jean-Frederic; Lim, Ho Yeong; Tran, Albert; Chan, Yi-Wah; McAdam, Paul; Wang, Evelyn; ANN-LII CHENG ; El-Khoueiry, Anthony B; Abou-Alfa, Ghassan K | Liver cancer | 15 | 14 | |
2023 | Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study | Kudo, Masatoshi; Finn, Richard S; Qin, Shukui; Han, Kwang-Hyub; Ikeda, Kenji; ANN-LII CHENG ; Vogel, Arndt; Tovoli, Francesco; Ueshima, Kazuomi; Aikata, Hiroshi; López, Carlos López; Pracht, Marc; Meng, Zhiqiang; Daniele, Bruno; Park, Joong-Won; Palmer, Daniel; Tamai, Toshiyuki; Saito, Kenichi; Dutcus, Corina E; Lencioni, Riccardo | Journal of hepatology | 6 | 6 | |